FDA staff shoots down Pfizer rare disease drug – Reuters

The only current treatment for the disease is a liver transplant, which keeps 80 percent of people alive after five years but requires taking immunosuppressant drugs. Two FDA reviewers said during a clinical trial that tafamidis was most …